Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen

Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen

There is paucity of data on sofosubvir (SOF)−based therapy in patients on maintenance hemodialysis (MHD). The objective of this report is to describe our experience using SOF-based direct antiviral agent (DAA) therapy in MHD patients in India. Methods: All patients on MHD and treated with SOF-based...

Full description

Bibliographic Details
Main Authors: Sanjay Kumar Agarwal, Soumita Bagchi, Raj Kumar Yadav
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Kidney International Reports
Subjects:
DAA
daclatasvir
HCV
hemodialysis
India
sofosbuvir
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917300955

Internet

http://www.sciencedirect.com/science/article/pii/S2468024917300955

Similar Items